U.S.C. homeSearch U.S. Code
U.S. CodeTitle 35Part II— Patentability of Inventions and Grant of PatentsChapter 10— Patentability of Inventions

35 U.S.C. § 103 (2026)

Conditions for patentability; non-obvious subject matter

Edition and currency
U.S. Code current through Pub. L. 119-102 (OLRC release point). The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTU.S. Code current through Pub. L. 119-102 (OLRC release point) cited 1953–2026 4,927citing cases
At a glance

Courts have cited this section in 4,927 opinions since 1953, 402 of them in the last five years. The most litigated part is subsection (a) (6 cases).

A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.

(July 19, 1952, ch. 950, 66 Stat. 798; Pub. L. 98–622, title I, § 103, Nov. 8, 1984, 98 Stat. 3384; Pub. L. 104–41, § 1, Nov. 1, 1995, 109 Stat. 351; Pub. L. 106–113, div. B, § 1000(a)(9) [title IV, § 4807(a)], Nov. 29, 1999, 113 Stat. 1536, 1501A–591; Pub. L. 108–453, § 2, Dec. 10, 2004, 118 Stat. 3596; Pub. L. 112–29, §§ 3(c), 20(j), Sept. 16, 2011, 125 Stat. 287, 335.)
The 20 cases that cite 35 U.S.C. § 103 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENTakeda Chem. Indus., Ltd. v. Alphapharm Pty., Ltd., 492 F.3d 1350 (Fed. Cir. 2007).
cites § 103 16×cited by 114 cases
Where it cites § 103
“Patent 4,687,777 was not shown to be invalid under 35 U.S.C. § 103 . Takeda Chem. Indus., Ltd.”
The case’s holding
Establishing prima facie obviousness of a new chemical compound requires identifying a reason in the prior art that would lead a chemist to modify a known compound in a particular manner.
Later courts cite it for
“it remains necessary to identify some reason that would have led a chemist to modify a known compound in a particular manner to establish prima facie obviousness of a new claimed compound.” · 9 citing courts
2
GREENIntercontinental Great Brands v. Kellogg North Am. Co., 869 F.3d 1336 (Fed. Cir. 2017).
cites § 103 10×cited by 39 cases
Where it cites § 103
“1 The district court granted Kellogg’s motion for sum- mary judgment of invalidity of all of the asserted claims (1, 3, 4, 6, 26, 32, 33, 34, 35, 36, 37, 39, and 42) under 35 U.S.C. § 103 (2006). 2 As the patent itself makes clear, the “frame” element is shown by prior art, such…”
The case’s holding
Summary judgment of obviousness is proper where the prior art, claim scope, and skill level are not materially disputed, and expert testimony is unnecessary for simple technologies.
Later courts cite it for
“we have recognized that some cases involve technologies and prior art that are simple enough that no expert testimony is needed.” · 7 citing courts
cites § 103 13×cited by 183 cases
Where it cites § 103
“We vacate the summary judgment of invalidity and dismissal of the infringement count, and remand to the district court.”
The case’s holding
Obviousness cannot be established by selective combination of prior art references based solely on hindsight without a specific reason for the combination existing in the prior art.
Later courts cite it for
“when prior art references require selective combination by the court to render obvious a subsequent invention, there must be some reason for the combination other than the hindsight gleaned from the invention itself.” · 9 citing courts
4
GREENNewell Companies, Inc. v. Kenney Mfg. Co., 864 F.2d 757 (Fed. Cir. 1989).
cites § 103 9×cited by 271 cases
Where it cites § 103
“4,006,770 (the ’770 patent), owned by Newell, were proved invalid for obviousness under the standard of 35 U.S.C. § 103 (1982), the district court granted Kenney’s reserved motion for directed verdict and entered judgment for Kenney on that issue holding claims 1, 2, 6 and 7…”
The case’s holding
The determination of obviousness is a question of law for the court when the underlying material facts are not in dispute.
Later courts cite it for
“this court has adopted the rule that prior decisions of a panel of the court are binding precedent on subsequent panels unless and until overturned in banc.” · 32 citing courts
5
YELLOWLoctite Corp. v. Ultraseal Ltd., 781 F.2d 861 (Fed. Cir. 1985).
cites § 103 8×cited by 364 cases
Flagged on editorial review. Overruled by Nobelpharma Ab v. Implant Innovations, Inc. on other grounds: 13 citing opinions limit it to other grounds and 1 says overruled outright.
Where it cites § 103
“A final rejection of the claims under 35 U.S.C. § 103 was made, the PTO Board of Appeals (Board) affirmed the rejection, and this Court affirmed the Board.”
The case’s holding
Particular limitations or embodiments appearing in a specification are generally not read into the claims.
Later courts cite it for
“in situations where there is no literal infringement but liability is nevertheless appropriate to prevent what is in essence a pirating of the patentee's invention.” · 9 citing courts
6
GREENGalderma Labs., L.P. v. Tolmar, Inc., 737 F.3d 731 (Fed. Cir. 2013).
cites § 103 9×cited by 64 cases
Where it cites § 103
“(collectively, “Galder- ma”) are not invalid under 35 U.S.C. § 103 . We find that the district court erred in finding the claims of the assert- ed patents not invalid as obvious.”
The case’s holding
When a claimed invention falls within a range disclosed in the prior art, the patentee bears the burden of production to show the prior art taught away or secondary considerations apply.
Later courts cite it for
“where there is a range disclosed in the prior art, and the claimed invention falls within that range, the burden of production falls upon the patentee to come forward with evidence” · 5 citing courts
7
GREENHughes Aircraft Co. v. United States, 717 F.2d 1351 (Fed. Cir. 1983).
cites § 103 8×cited by 279 cases
Where it cites § 103
“On January 10, 1966, the examiner rejected all claims under 35 U.S.C. § 103 as un-patentable over earlier cited art and newly cited U.”
The case’s holding
An accused product infringes under the doctrine of equivalents if it performs substantially the same function in substantially the same way to achieve the same result.
Later courts cite it for
“depending on the nature and purpose of an amendment, it may have a limiting effect within a spectrum ranging from great to small to zero.” · 10 citing courts
8
REDAm. Hoist & Derrick Co. v. Sowa & Sons, Inc., 725 F.2d 1350 (Fed. Cir. 1984).
cites § 103 6×cited by 557 cases
Abrogated by Therasense, Inc. v. Becton, Dickinson and Co. on other grounds: 4 citing opinions limit it to other grounds and 1 says abrogated outright.
Where it cites § 103
“49(b), stating that each claim was invalid under 35 U.S.C. § 103 and for “fraud on the Patent Office.”
The case’s holding
The challenger of a patent bears the burden of overcoming the deference due to a qualified government agency presumed to have properly performed its job.
Later courts cite it for
“has the added burden of overcoming the deference that is due to a qualified government agency presumed to have properly done its job.” · 29 citing courts
9
GREENStratoflex, Inc. v. Aeroquip Corp., 713 F.2d 1530 (Fed. Cir. 1983).
cites § 103 6×cited by 538 cases
Where it cites § 103
“§ 102 (b); for obviousness, 35 U.S.C. § 103 ; or because the claims were indefinite, 35 U.”
The case’s holding
Secondary considerations of nonobviousness must be considered as part of the overall evidence in an obviousness analysis rather than only when the decision-maker remains in doubt.
Later courts cite it for
“may often be the most probative and cogent evidence in the record” · 38 citing courts
10
cites § 103 8×cited by 170 cases
Where it cites § 103
“3,672,371 (’371) issued June 27, 1972, for “Sanitary Napkin with Improved Adhesive Fastening Means” was not infringed, “unenforceable” because of “fraud on the PTO,” and invalid under 35 U.S.C. § 103 . We affirm the holding of non-infringement, reverse the holdings of…”
The case’s holding
Patent claims must be construed identically for both infringement and validity analyses.
Later courts cite it for
“claims ... must be construed in the identical way for both infringement and validity.” · 4 citing courts
11
GREENTokai Corp. v. Easton Enter., Inc., 632 F.3d 1358 (Fed. Cir. 2011).
cites § 103 6×cited by 100 cases
Where it cites § 103
“On the issue of invalidity, the district court determined that there existed no genuine issue of material fact as to the obviousness of the asserted claims over the four prior art references asserted by Easton: U.”
The case’s holding
A strong case of prima facie obviousness cannot be overcome by a far weaker showing of objective indicia of nonobviousness.
Later courts cite it for
“if commercial success is due to an element in the prior art, no nexus exists.” · 5 citing courts
12
GREENPfizer, Inc. v. Apotex, Inc., 480 F.3d 1348 (Fed. Cir. 2007).
cites § 103 4×cited by 293 cases
Where it cites § 103
“By statute, a claimed invention is unpatentable if the differences between it and the prior art “are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art.”
The case’s holding
A patent challenger must prove by clear and convincing evidence that a skilled artisan would have been motivated to combine prior art teachings with a reasonable expectation of success.
Later courts cite it for
“show by clear and convincing evidence that a skilled artisan would have been motivated to combine the teachings of the prior art references to achieve the claimed invention, and that the skilled artisan would have had a reasonable expectation of success in doing so.” · 30 citing courts
13
GREENIn re Charles D. Huston & Darryl J. Cornish, 308 F.3d 1267 (Fed. Cir. 2002).
cites § 103 10×cited by 27 cases
Where it cites § 103
“PROCEEDINGS BELOW The examiner rejected claims 1, 5-18, and 21-26 as obvious under 35 U.S.C. § 103 (a), relying on various combinations of eight references: U.”
Later courts cite it for
“its conclusions are cryptic, but . . . supported by the record.” · 2 citing courts
14
GREENAventis Pharma S.A. v. Hospira, Inc., 675 F.3d 1324 (Fed. Cir. 2012).
cites § 103 6×cited by 81 cases
Where it cites § 103
“After a bench trial, the district *1318 court found, inter alia, that claim 5 of the '561 patent and claim 7 of the '512 patent were invalid for obviousness under 35 U.S.C. § 103 , that claim 7 of the '512 patent was not infringed, and that both the '561 and '512 patents were…”
The case’s holding
A claim term is not limited beyond its ordinary meaning merely because all embodiments in the specification contain a particular limitation.
Later courts cite it for
“it is . . . not enough that the only embodiments, or all of the embodiments, contain a particular limitation' to limit a claim term beyond its ordinary meaning.” · 10 citing courts
15
GREENEli Lilly & Co. v. Zenith Goldline Pharm., Inc., 364 F. Supp. 2d 820 (S.D. Ind. 2005).
cites § 103 14×cited by 14 cases
Where it cites § 103
“§ 102 , as obvious under 35 U.S.C. § 103 , under the doctrine of double patenting, or as barred by prior public use under 35 U.”
The case’s holding
Failure to execute a confidentiality agreement does not necessarily constitute a controlling factor in determining whether a prior public use exists to invalidate a patent.
16
GREENBASCOM Global Internet Servs., Inc. v. AT&T Mobility LLC, 827 F.3d 1341 (Fed. Cir. 2016).
cites § 103 2×cited by 408 cases
Where it cites § 103
“The district court’s analysis in this case, however, looks similar to an obvi- ousness analysis under 35 U.S.C. § 103 , except lacking an explanation of a reason to combine the limitations as claimed.”
The case’s holding
An inventive concept exists in a non-conventional and non-generic arrangement of known, conventional components that provides a specific technical solution to a problem.
Later courts cite it for
“an inventive concept can be found in the non-conventional and non-generic arrangement of known, conventional pieces.” · 119 citing courts
17
GREENPanduit Corp. v. Dennison Mfg. Co., 774 F.2d 1082 (Fed. Cir. 1985).
cites § 103 11×cited by 54 cases
Where it cites § 103
“At the outset of its statement from the bench, the district court reflected a clear instinct for the proper parameters of deci-sionmaking under 35 U.S.C. § 103 : It is not appropriate for the Court to engage in hindsight.”
The case’s holding
Obviousness is determined by whether the invention would have been obvious to a person skilled in the art at the time of invention rather than through hindsight analysis.
Later courts cite it for
“the test is whether the subject matter of the claimed inventions would have been obvious to one skilled in the art at the time the inventions were made, not what would be obvious to a judge after reading the patents in suit and hearing the testimony.” · 4 citing courts
18
GREENIn re McKellin, 529 F.2d 1324 (C.C.P.A. 1976).
cites § 103 20×cited by 16 cases
Where it cites § 103
“The sole basis of rejection is under 35 U.S.C. § 103 , the rejected claims being held obvious in view of the subject matter of the counts of the interference.”
19
GREENIn re Werner Kotzab, 217 F.3d 1365 (Fed. Cir. 2000).
cites § 103 8×cited by 112 cases
Where it cites § 103
“DECISION Werner Kotzab appeals from the final decision of the Board of Patent Appeals and Interferences (“Board”) holding claims 1-10 in reexamination number 90/004,441 unpatentable for obviousness under 35 U.S.C. § 103 (a). See Ex Parte Kotzab, Paper No.”
The case’s holding
Establishing obviousness through a combination of prior art elements requires a motivation, suggestion, or teaching to make the specific combination claimed.
Later courts cite it for
“substantial evidence is something less than the weight of the evidence but more than a mere scintilla of evidence.” · 7 citing courts
20
REDDuplan Corp. v. Deering Milliken, Inc., 444 F. Supp. 648 (D.S.C. 1977).
cites § 103 12×cited by 42 cases
Reversed in part by The Duplan Corporation, Burlington Industries, Inc., Dixie Yarns, Inc., Frank Ix & Sons Virginia Corporation, Hemmerich Industries, Inc., Jonathan Logan, Inc., Lawrence Texturing Corp., Leon-Ferenbach, Inc., (…
Where it cites § 103
“The plaintiffs’ third ground of attack on the ’375 patent is that it is void for obviousness under 35 U.S.C. § 103 which reads: “A patent may not be obtained though the invention is not identically disclosed or described as set forth in section 102 of this title, if the…”
The case’s holding
Narrow patent claims are evidence that limitations should not be written into broader claims, and interdependent royalty programs may be preserved rather than destroyed by relief against patent misuse.
Later courts cite it for
“the presence of narrow claims ... is evidence that limitations are not to be written into the broader claims.” · 2 citing courts

Show all 4,927 citing cases (list view) →

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
195219892026

One bar per 2 years. Tallest: 290 cases in 1966–1967. 2026 is a partial year. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
Fed. Cir.1,331C.C.P.A.781D. Del.321S.D.N.Y.160N.D. Ill.147D.D.C.1377th Cir.1039th Cir.102

The 8 courts with the most citing cases, of 115 courts in all.

By subsection
(a)6 cases
Duhn Oil Tool, Inc. v. Cooper Cameron Corp., 818 F. Supp. 2d 1193 (E.D. Cal. 2011).
Bushnell, Inc. v. Brunton Co., 673 F. Supp. 2d 1241 (D. Kan. 2009).
LAMPI, LLC v. Am. Power Prods., Inc., 65 F. Supp. 2d 757 (N.D. Ill. 1999).
In re Scroggie, 442 F. App'x 547 (Fed. Cir. 2011).
In re Lemay, 660 F. App'x 919 (Fed. Cir. 2016).
Showing the top 5 of 6. More in the list view →

Show all 4,927 citing cases (list view) →

Enactment and amendments
(July 19, 1952, ch. 950, 66 Stat. 798; Pub. L. 98–622, title I, § 103, Nov. 8, 1984, 98 Stat. 3384; Pub. L. 104–41, § 1, Nov. 1, 1995, 109 Stat. 351; Pub. L. 106–113, div. B, § 1000(a)(9) [title IV, § 4807(a)], Nov. 29, 1999, 113 Stat. 1536, 1501A–591; Pub. L. 108–453, § 2, Dec. 10, 2004, 118 Stat. 3596; Pub. L. 112–29, §§ 3(c), 20(j), Sept. 16, 2011, 125 Stat. 287, 335.)
Amendment years (notes): 2011, 2004, 1999, 1995, 1984
Versions

Edition shown: U.S. Code current through Pub. L. 119-102 (OLRC release point). Syfert holds no earlier or later version of this section.

U.S.C. Home  |  Search U.S. Code  |  Search cases for this section  |  syfert.com